51.07USD-0.35%Mkt Cap: 1.53B $P/E: 27.612d ago
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot A…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap1.53B $
Enterprise Value2.34B $
Revenue (TTM)1.37B $
Gross Profit750.48M $
Net Income (TTM)47.05M $
Revenue/Share44.70 USD
Last Price51.07 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.9K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)27.61
P/E (Forward)10.75
PEG1.84
EV/EBITDA10.27
EV/Revenue1.70
P/S1.12
P/B1.48
EPS (TTM)1.85
EPS (Forward)4.78
52W Range
31.4478% of range56.64
52W High56.64 USD
52W Low31.44 USD
Profitability
Gross Margin54.59%
Oper. Margin14.64%
EBITDA Margin16.58%
Profit Margin3.42%
ROE4.55%
ROA2.02%
Growth
Revenue Growth0.30%
Earnings Growth11.20%
Cash Flow & Leverage
Operating CF170.69M $
CapEx (TTM)19.81M $
FCF Margin9.58%
FCF Yield8.59%
Net Debt796.92M $
Net Debt/EBITDA3.50
Balance Sheet
Debt/Equity0.81
Current Ratio1.48
Quick Ratio0.61
Book Value/Sh34.73 USD
Cash/Share1.246 USD
Dividends
Fwd Div Rate0.8000 USD
Trail. Div Rate0.2000 USD
Div. Yield1.56%
5Y Avg Yield1.02%
Payout Ratio10.81%
Ex-Div DateSep 15, 2025
Pay DateOct 3, 2025
Splits
Last Split3:2
Split DateSep 10, 2001
Analyst Consensus
Rating—
Target (Mean)45.50 USD
Upside (mean)-10.9%
Target Range43.00 USD – 49.00 USD
$43.00-10.9% to mean$49.00
# Analysts6
Ownership
Shares Out.29.95M
Float29.66M
Insiders0.43%
Institutions116.71%
Short Interest
Short Ratio2.9d
Short % Float8.87%
Short % Out.7.46%
Shares Short2.23M
Short (prev mo.)2.53M
Technical
SMA 5041.48 (+23.1%)
SMA 20040.16 (+27.2%)
Beta0.90
S&P 52W Chg18.16%
Avg Vol (30d)559.17K
Avg Vol (10d)347.00K
Technical Indicators
RSI (14)66.1
MACD2.6870
MACD Signal2.8387
MACD Hist.-0.1517
BB Upper54.42 USD
BB Middle47.95 USD
BB Lower41.48 USD
BB Width26.99%
ATR (14)1.998 USD
Vol Ratio (20d)0.42x